HealthStream Reports 7.4% Q4 Revenue Growth, Canaccord Cuts Target to $21
Canaccord cut HealthStream’s price target from $25 to $21 while maintaining a Hold rating, citing Q4 revenue of $79.7M (7.4% increase) and EBITDA of $18.8M (16.4% gain). Full-year revenue rose 4.3% to $304.1M, EBITDA climbed 7.5% to $71.8M, shares repurchased totaled $10M and the dividend rose to $0.035.
1. Analyst Update
Canaccord cut its price target for HealthStream from $25 to $21 and maintained a Hold rating, noting the company’s resilience to AI-driven pressures faced by SaaS firms.
2. Fourth-Quarter Results
HealthStream delivered Q4 revenue of $79.7 million, up 7.4% year-over-year; non-GAAP operating income reached $6.2 million, non-GAAP EPS was $0.18 after excluding a $3.8 million stock-based compensation charge, and adjusted EBITDA rose 16.4% to $18.8 million.
3. Full-Year Financials and Capital Deployment
For the full year, revenue grew 4.3% to $304.1 million and adjusted EBITDA climbed 7.5% to $71.8 million. The company completed two acquisitions, repurchased $10 million in shares and increased its quarterly dividend to $0.035 per share.
4. Business Positioning
Management emphasized that HealthStream’s focus on healthcare workforce training, credentialing and compliance platforms provides a competitive edge in adapting to AI challenges affecting broader SaaS providers.